It is common strategy in medical research to categorize a continuous covariable before evaluating its prognostic impact on clinical outcome. In most cases the covariable is divided into just two groups. The chosen cutpoint is either a value already published in other studies, or a certain sample quantile like the median, or a so-called ‘optimal cutpoint’, that is the value which corresponds to the most significant relation with outcome. Because the multiple testing problem is often ignored, the term ‘optimal ’ is misleading in this context. Altman et al. (1994) suggest that the method be called the ‘minimum P-value approach ’ instead, and present simulation and asymptotic results of the inflation of the type I error rate. Recently the influ...
<p>Cartoon illustrating two distinct, unrelated, values that are both called “threshold”. The statis...
For testing the efficacy of a treatment in a clinical trial (e.g. treatment vs. control), the Cox pr...
The early evaluation of prognostic tumour markers is commonly performed by comparing the survival of...
The assessment of prognostic markers is key to the improvement of therapeutic strategies for cancer ...
Competing risks is commonly encountered in survival data. While fundamental methods have been establ...
Multivariable regression models are powerful tools that are used frequently in studies of clinical o...
<p>Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreati...
In the analysis of epidemiologic data in which exposure has been measured on a continuous scale, cut...
<p>Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreati...
There are two important statistical models for multivariate survival analysis, propor-tional hazards...
International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a...
<p>(A) Distribution of CE index over all patients and the respective group sample sizes (<i>n</i>). ...
In many clinical studies, continuous variables such as age, blood pressure and cholesterol are measu...
Continuous predictors are routinely encountered when developing a prognostic model. Investigators, w...
Overall survival curves of different diagnosis-to-treatment intervals for the validation cohort by c...
<p>Cartoon illustrating two distinct, unrelated, values that are both called “threshold”. The statis...
For testing the efficacy of a treatment in a clinical trial (e.g. treatment vs. control), the Cox pr...
The early evaluation of prognostic tumour markers is commonly performed by comparing the survival of...
The assessment of prognostic markers is key to the improvement of therapeutic strategies for cancer ...
Competing risks is commonly encountered in survival data. While fundamental methods have been establ...
Multivariable regression models are powerful tools that are used frequently in studies of clinical o...
<p>Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreati...
In the analysis of epidemiologic data in which exposure has been measured on a continuous scale, cut...
<p>Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreati...
There are two important statistical models for multivariate survival analysis, propor-tional hazards...
International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a...
<p>(A) Distribution of CE index over all patients and the respective group sample sizes (<i>n</i>). ...
In many clinical studies, continuous variables such as age, blood pressure and cholesterol are measu...
Continuous predictors are routinely encountered when developing a prognostic model. Investigators, w...
Overall survival curves of different diagnosis-to-treatment intervals for the validation cohort by c...
<p>Cartoon illustrating two distinct, unrelated, values that are both called “threshold”. The statis...
For testing the efficacy of a treatment in a clinical trial (e.g. treatment vs. control), the Cox pr...
The early evaluation of prognostic tumour markers is commonly performed by comparing the survival of...